Frederick-based RoosterBio raised more than $15 million in a Series B funding round as the cell manufacturing technology company looks to grow its team.
The funding was led by Dynamik Capital, with participation from new and existing investors. RoosterBio is expecting to close the funding round at $22 million by the end of August.
Founded in 2013, RoosterBio developed technology to simplify biomanufacturing of specific kinds of stem cells that are commonly used in regenerative medicine. There’s a need to increase access to the the stem cells among researchers and scientists, the company says. The products are designed to increase availability of the stem cells for use, as well as making them available more quickly and reducing cost.
“It is critical that we empower scientists to get innovative products to the market more efficiently in order to develop life-saving cures,” Daniella Kranjac, founding partner of Dynamik Capital, said in a statement. “RoosterBio’s pioneering biotechnology platform is driving the revolutionary field of regenerative medicine which has the potential to develop therapies for previously untreatable diseases and conditions.”
With the funding, RoosterBio is looking to expand its team as the company grows internationally, and bolster R&D on new solutions.
RoosterBio launched at the Frederick Innovative Technology Center, Inc., and last year moved into a new facility on Westview Drive. The company took additional space amid growth at the beginning of this year, as well.
This form of art blends science and technology to tell stories through biological products
Why Baltimore rose to the ‘top of the list’ when this biotech team needed a new HQ
KaloCyte moves to University of Maryland BioPark
Get to know SmartLogic’s culture of plants, podcasts and productive client relationships
UMB grants licensing option for anticancer drug that uses Anthrax
AgeneBio receives $3.4M for development of Alzheimer’s treatment
Frederick’s Veralox Therapeutics raises $5.4M seed round
Entrepreneurs, think it’s too early to engage a legal partner? It’s not.
Sign-up for daily news updates from Technical.ly Baltimore